Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

NCT01484262 · Completed

Last updated 2026-05-28

This clinical trial compares the effects of liraglutide and insulin on the quality of life of adults living with type 2 diabetes.

Status Completed The study has finished.

Type Observational

Participants 1,344 people

Who can join Ages 18–70 · all sexes

Timeline Started 2011-11 · est. completion 2014-10

Where 1 site · Germany

What this study is testing ClinicalTrials.gov NCT01484262 ↗

Description as written by the study sponsor.

This study is conducted in Europe. The intention of this health service research study is to obtain data from daily routine to evaluate the quality of life and the costs of the disease for patients with type 2 diabetes mellitus.

Treatments tested

liraglutide Drug

Patients will be treated according to routine clinical practice at the discretion of the treating physician according to current labelling.
insulin Drug

Any insulin in any device available on the market may be used by patients as part of routine clinical practice according to current labelling.

Main thing measured	Diabetes-related quality of life assessed by ADDQoL (Audit of Diabetes-Dependent Quality of Life)
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01484262 ↗